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ÖZET
Kronik dissemine langerhans hücreli 
histiyositozis’in ağız bulguları: Bir vaka raporu  
Histiositozis X, histiyosit-türevi hücrelerin prolifeasyonu ile karak-
terize klinik-patolojik bozukluk spektrumunda kollektif bir terim 
olarak tanımlanmıştır. Bu lezyonda gösterilen tipik histiositik hücreler 
Langerhans hücreleri olarak tanımlanmış ve bu durum Langerhans 
hücre histiositozis olarak gösterilmiştir. Kronik yayılmış Langerhans 
hücreli histiositozis kemik, deri ve iç organları içine alan bir hasta-
lıktır (Hand-Schüller-Christian hastalığı). Kronik yayılmış Langerhans 
hücreli histiositozis triadı- kemik lezyonları, ekzoftalmi ve diabetus 
insipidus- kronik yayılmış hastalıkların çok azında gözükür. Kronik 
yayılmış hastalıkta sıklıkla morbidite görülür, fakat hastalık yüzünden 
az sayıda ölümle sonuçlanır. Bu çalışmanın amacı 34 yaşındaki erkek 
hastada görülen Kronik yayılmış Langerhans hücreli histiositozis 
hastalığını sunmaktır. Klinik muayeneye ek olarak hastaya medikal, 
panoramik ve histolojik inceleme yapılmıştır. Radyolojik ve histolojik 
dental pratikte önemlidir ve klinisyenler dental ve mukozal anomali-
lerin varlığında dikkatli olmalıdır.
Anahtar sözcükler: Langerhans hücresi, Kronik yayılmış Langerhans 
hücreli histiositozis, sintigrafi
ABS TRACT
Oral manifestations of chronic disseminated 
langerhans cell histiocytosis: a case report 
The term histiocytosis X was introduced as a collective designation 
for a spectrum of clinopathologic disorders characterized by 
proliferation of histiocyte-like cells. The distinctive histiocytic cells 
present in this lesion have been identified as Langerhans cells, and 
the condition is now designated as Langerhans cell histiocytosis. 
Chronic disseminated langerhans cell histiocytosis is a disease 
involving bone, skin, and viscera (Hand-Schüller-Christian disease). 
The often-cited Chronic disseminated langerhans cell histiocytosis 
triad (bone lesions, exophthalmos and diabetes insipidus) is 
present in only a few patients with chronic disseminated disease. 
Chronic disseminated disease is often associated with considerable 
morbidity, but few patients die as a result of the disease. The 
aim of this report is to present a case of Chronic disseminated 
langerhans cell histiocytosis in a 34-year-old male patient. In addition 
to clinical examination, the patient was imaged using medical 
and panoramic examination; and histological examination was 
performed. Radiological and histological examinations are important 
in dental practice and clinicans must be watchful of the presence 
of dental and mucosal abnormalities suggesting the presence of 
systemic disorders.
Key words: Langerhans cells,  Chronic disseminated langerhans cell 
histiocytosis, scintigraphy
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 INTRODUCTION
 Langerhans cell histiocytosis (LCH), is a rare disease 
characterized by a proliferation of Langerhans cells or their 
precursors (1,2). It is estimated that the disease occurs at 
the rate of 0.2 to 0.5 cases per 100.000 children per year. The 
skull, mandible, ribs, vertebra, and long bones are involved. 
Head and neck lesions are common and 10% of all patients 
have oral lesions (3,4). 
 The etiology and pathogenesis of LCH remain obscure. 
It is thought that the disease may result from exuberant 
reaction to an unknown antigenic challenge (5,6). A 
deficiency of suppressor T cells, as well as low levels of 
serum thymic factor, suggest the presence of a thymic 
abnormality in LCH (6,7). Histologically, LCH is characterized 
by the proliferation of large cells with abundant cytoplasm, 
indistinct cell borders, and oval to reniform nuclei. These 
cells are most often arranged in sheets and may be admixed 
with various numbers of eosinophils and other inflammatory 
cells. Multinucleated giant cells and foci of necrosis may be 
noted. Langerhans cells cannot be differentiated from 
other histiocytes by routine histological staining; therefore 
additional histological diagnostic methods are needed. 
Using immunohistochemistry, the mononuclear histiocytic 
cells CD1a, S-100 and langerin (CD207) can be detected 
(1,2,8,9). This condition has been described as a neoplastic 
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process because of the monoclonal proliferation of LCs, as 
LCHCs express many LC antigens like CD1a, S-100 and 
langerin (CD207); more recent studies highlight the 
possibility that LCH is the result of an immune dysregulation 
(2,8). 
 The disease has been classified by Lichtenstein 
depending on the patient’s age at onset and distribution of 
the lesions as follows: Eosinophilic granuloma (chronic 
focal LCH), which refers to solitary or multiple bone lesions 
with no extra-skeletal involvement;  Chronic disseminated 
Langerhans Cell histiocytosis (Chronic disseminated LCH) 
(Hand-Schüller-Christian disease), which is a specific clinical 
triad of lytic bone lesions, exophthalmus, and diabetes 
insipidus; Letterer-Siwe disease (acute disseminated LCH), 
which is a malignant form of LCH (6,10).
 The oral changes are the first clinical signs in all forms of 
LCH and on some occasions the oral cavity may be the only 
affected area (11). The incidence of oral lesions in LCH is 
77% (6); therefore patients suspected of having the disease 
should be referred to an odontologist. Tenderness, pain and 
swelling are common patient complaints. The gingival 
tissues are inflamed, hyperplastic, and ulcerated. Ulcerative 
or a proliferative gingival mass may develop if the disease 
destroys the bone. The jaws may exhibit solitary or multiple 
radiolucent lesions. Bone lesions with a sharply 
circumscribed, punched-out appearance may occur in the 
central aspect of the mandible or maxilla. The lesions often 
affect the alveolar bone. In alveolar lesions the bone around 
teeth is destroyed, as a result, the begin to move 
progressively giving rise to the characteristic ‘floating teeth’, 
completely surrounded by a radiolucent defect 
accompanied by dental displacement, odontalgia and on 
occasions cervical adenopathies (12,13). Alveolar and 
periodontal lesions may resemble a periapical process of 
dental or periodontal origin (6,14,16).
 The diagnosis is confirmed by histopathological 
examination supported by clinical and radiographic 
examination. Although there is not a specific laboratory 
test for LCH, blood and urine tests reveal the extent and 
seriousness of the disease (6). X-ray of thorax, computed 
tomography (CT), magnetic resonance imaging (MRI) and 
bone scintigraphy are useful to evaluate the affected areas 
of the bone and soft tissues (6,15,16,14,15). Panoramic 
radiography, intraoral radiography and even maxillofacial 
CT are necessary to localize and delimit lytic lesions in any 
of the previously-described forms (6,14). Bone scintigraphy 
of the whole body is indicated to evaluate multiple 
involvements and to discard polyostotic disease. The result 
of this test will show hyperuptake in affected bone (6,15). 
Given the periodontal and bone characteristics of LCH, 
noninfectious bone loss associated with “floating teeth” 
should be included in the differential diagnosis. 
Furthermore, alveolar and periodontal lesions could 
produce an erroneous diagnosis of advanced periodontal 
disease, or have similar appearance to a periapical process 
of dental or periodontal origin (6,16). Treatment options are 
surgical management, chemotheraphy, radiation theraphy 
and combinations of these modalities (4). 
 Chronic disseminated LCH usually appears in children 
or young adults. It manifests with the characteristic triad of 
exophthalmos, osteolytic lesions of the cranium and 
diabetes insipidus. The aim of this report is to present a case 
of Chronic disseminated LCH in a male patient. 
 CASE REPORT 
 A 34-year-old male was admitted to the Department of 
Oral Diagnosis and Radiology, Marmara University, Faculty 
of Dentistry, Istanbul, Turkey suffering from a painful and 
non-bleeding palatal swelling for 3 months. The medical 
history revealed that diabetes insipidus was diagnosed 5 
years ago and treated with desmopressin acetate (DDAVP). 
In addition, the patient reported to be suffering from 
osteoporosis and was treated with calcium. The family 
history was unremarkable. 
 The intraoral examination revealed an exophytic large 
ulcerative mass with an irregular and pebbled surface of 
the palatal mucosa (Fig. 1). Severe bone loss appeared in 
the maxillary molar regions on panoramic radiograph (Fig. 
2). Antero-Posterior (AP) and lateral radiographic views of 
the skull revealed a slight lytic appearance on the right 
parietal bone (Figure 3). Routine blood tests, alkaline 
phosphatase (ALP), calcium, phosphorus, parathyroid 
hormone (PTH) and calcitonin levels were normal. An 
incisional biopsy of the mass was performed under local 
anaesthesia and the specimen was sent for histopathological 
examination to the Department of Oncologic Cytology and 
Tumor Pathology, Institute of Oncology, İstanbul University. 
Histopathologic features revealed an infiltrate of lympho-
monocytes together with eosinophilic and neutrophilic 
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cells. The identification of lesional Langerhans cells was 
necessary to confirm the diagnosis. The diagnosis was 
confirmed by immunohistochemistry techniques (CD1a) 
(Fig. 4, 5). The histopathologic diagnosis was Langerhans 
cell histiocytosis. Chronic disseminated LCH term was given 
to Langerhans cell histiocytosis causing exophthalmos, 
diabetes insipidus and lytic skull lesions. Therefore, clinical 
and histopathological diagnosis of Chronic disseminated 
LCH was done in this patient. 
 Due to the histopathological report, the patient was 
examined with technetium scintigraphy and bone SPECT to 
evaluate any bone involvement. Anterior and posterior 
projections of bone scan using technetium (Tc)-99m-
labelled methylene diphosphate showed multiple foci of 
intense activity on right parietal bone of cranium, mandible 
and right femur (Fig. 6); therefore, the patient was referred 
to the Faculty of Medicine. 
Figure 1: The intraoral examination revealed an exophytic large ulcerative 
mass with an irregular and pebbled surface of the palatal mucosa.
Figure 3: Antero-posterior and lateral radiographic views of the skull 
revealed a slight lytic appearance on the right parietal bone.
Figure 5: Langerhans histiocytes are positively stained with CD1a 
immunohistochemically (CD1a, x400). 
Figure 4: Microscopic appearance of Langerhans cell histiocytosis. 
Beneath the surface epithelium, infiltration of Langerhans histiocytes, 
lymphocytes and eosinophilic granulocytes are observed in the 
connective tissue (H&E, x100). 
Figure 2: Panoramic radiograph showed severe bone loss in the 
maxillary molar regions.
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 DISCUSSION 
 Chronic disseminated LCH is an infrequent disorder of 
childhood (13). The approximate incidence is one case in 
every 3,300,000 individuals (17). The disease usually appears 
in the first decade of life, with no particular sex predilection 
(13). In our case report the patient was a 34 year old. The 
lesion was an exophytic large ulcerative mass with an 
irregular and pebbled surface of the palatal mucosa and 
radiographic examination revealed severe bone loss in the 
maxillary molar regions. The most commonly affected 
bones are skull and facial bones, the femur, ribs, vertebrae 
and humerus (13). Thus, this lesion is similar to those 
described in the literature (8,11,16). 
 Chronic disseminated LCH has classically been defined 
as a triad comprising diabetes insipidus, exophthalmos and 
bone alterations, though only 25% of patients present the 
full picture (13,17), and according to Garcia-Pola et al. (18), 
the complete triad is actually found in less than 10% of 
cases. Similarly, Minguez et al. (13) observed that only in 
one of their patients the full triad was identified, while two 
patients presented two of the alterations (3 with bone 
lesions and diabetes insipidus, and 2 with bone lesions and 
exophthalmos). In our case, like the other studies (13,18), 
we identified two of the alterations (bone lesions and 
diabetes insipidus).
 The diagnosis of LCH is based on histological and 
immuno-phenotypic examination of a biopsy of lesional 
tissue in addition to clinical and radiological features (19). 
LCH is characterized by the proliferation of large cells with 
abundant cytoplasm, indistinct cell borders, and oval to 
reniform nuclei. These cells are most often arranged in 
sheets and may be admixed with various numbers of 
eosinophils and other inflammatory cells. In addition, 
macrophages, multinucleated giants cell and foci of 
necrosis may also be noted. The ultrastructure of tumor 
cells shows unique, rod-shaped cytoplasmic structures, 
which are identical to Birbeck granules, present in normal 
Langerhans cells (20). In immunohistochemical stains, 
CD1a, S100 protein and Langerin (CD207) are three markers 
widely used for identifying Langerhans cells (21). Electron 
microscopy is no longer recommended since it has been 
shown that the expression of Langerin (CD207) fully 
correlates with the presence of Birbeck granules on electron 
microscopy, which was previously one of the criteria 
required for definitive diagnosis (19). It should be noted 
that CD1a is a specific marker for normal Langerhans cells 
and the pathologic cells in LCH. The monoclonal antibody 
reactive to CD1a is effective for immunohistochemical 
analysis of formalin-fixed tissue, replacing the less specific 
S100 protein for confirmation of LCH (20). Our data showed 
that this case, immunostained with CD1a, was strongly 
positive with the markers. This finding demonstrates that 
LCH can be simply diagnosed histologically by the oral 
pathologists, and the use of immunostaining with CD1a 
aids in confirming the diagnosis. 
 Diagnosis should be based on clinical-radiological-
pathological evidence. The classic presentation of LCH in 
jaws often results in loosening or premature exfoliation of 
teeth and precocious eruption of permanent teeth. A 
differential diagnosis should include juvenile or diabetic 
periodontitis, hypophosphatasia, leukemia, cyclic 
neutropenia and metastatic malignant neoplasms under 
these conditions. Lesions located in periapical site may 
mimic a periapical cyst or granuloma. Solitary radiolucent 
lesions in the central aspects of the jaws should be 
differantiated from odontogenic tumors and cysts and 
numerous well-circumscribed radiolucencies may suggest 
multiple myeloma (19,20). 
 The most widely used treatment options comprise 
chemotherapy, radiotherapy, surgery and corticotherapy. 
Diverse therapeutic options are available and no consensus 
exists over the best treatment combination. Treatment of 
LCH is constrained both by natural history of the disease as 
Figure 6: Anterior and posterior projections of bone scan using 
technetium (Tc)-99m labelled methylene diphosphate showed 
multiple foci of intense activity on right parietal bone of cranium, 
mandible bone and right femur.
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well as the location and extent of the lesions and degree of 
organ dysfunction. Occasionally different therapeutic 
approaches are required in response to changes in 
behaviour of the disease (6,13,22). The combination of 
chemotherapy and systemic corticosteroids is the most 
often prescribed treatment approach, with dose variations 
according to the outbreaks of the disease (13). The 
Histiocyte Society performed three major study protocols 
for paediatric LCH (LCH-I, LCH-II, LCH-III); and more recently, 
a protocol for adult onset was started, considering 
vinblastine plus prednisone for multisystem disease, but 
the therapy regimen for adults still remains dubious: it can 
vary from watchful waiting to local therapy (surgery and 
radiotherapy) to systemic chemotherapy (cladribine, 
thalidomide) in the refractory cases (1).
 The prognosis of LCH is difficult to assess since this is a 
rare disease with clinical variability. The most important 
factors that may worsen the prognosis are firstly, visceral 
involvement, as this has a negative effect on survival; 
secondly, where age at first presentation is less than two 
years since mortality rises to 50%; and thirdly, when the 
disease spreads to various bones or soft tissues (6,12).
 In conclusion, the management of long-term sequelae 
is not specific to LCH and all therapeutic options, like 
growth hormone therapy, and radiological and histological 
examinations are important in dental practice; and clinicans 
must be watchful of the presence of dental and mucosal 
abnormalities.
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